AVTX AVALO THERAPEUTICS
Health Care · Russell 2000
Next earnings: not announced yet
What 17 analyst firms say about AVALO THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
15 rated views · 17 analyst/firm records · 17 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8064
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8040
Recent analyst activity · last 90 days
Our tracked history has 9 reports on AVTX from 8 analyst firms in the last 90 days (17 firms in the past year).
Comparing each firm's latest target with its previous one: 4 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 2 downgrades.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Alec Stranahan | Buy | 12 Jun 2026 | 35.00 USD |
| BTIG | Julian Harrison | Buy | 23 Oct 2026 | Conflicting reports · excluded |
| Cantor Fitzgerald | Prakhar Agrawal | Buy | 24 Jul 2026 | — |
| Citigroup | Unnamed analyst | Buy | 6 May 2026 | — |
| Citizens JMP | Jason Butler | Buy | 14 May 2026 | 55.00 USD |
| Guggenheim | Yastin Suneja | Hold | 23 Oct 2026 | 48.00 USD |
| H.C. Wainwright | Mitchell S. Kapoor | Hold | 23 Oct 2026 | 30.00 USD · 5 Oct 2026 |
| Leerink Partners | Thomas Smith | Buy | 6 Jul 2026 | 38.00 USD |
| Lucid Capital Markets | Dev Prasad | Buy | 6 May 2026 | 55.00 USD |
| Mizuho | Joseph Catanzaro | Buy | 14 May 2026 | 45.00 USD |
| Oppenheimer | Unnamed analyst | — | 26 Oct 2026 | 16.00 USD |
| Piper Sandler | Yasmeen Rahimi | Buy | 1 Oct 2026 | 60.00 USD |
| TD Cowen | Stacy Ku | Buy | 24 Feb 2026 | — |
| Wedbush | Robert Driscoll | Buy | 23 Oct 2026 | 22.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Aug 2026 | — |
| Wolfe Research | Andy Chen | Buy | 9 Apr 2026 | 48.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:11 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.